Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IG001119 in Healthy Participants
NCT07618247Phase 1Recruiting
- Sponsor
- Iongen Therapeutics
- Start
- Jul 2026
- Primary completion
- Apr 2027
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of IG001119 in pain (4 arms), sponsored by Iongen Therapeutics. Primary endpoint: Incidence and severity of adverse events at Day 23. Started Jul 2026; status: recruiting.
02
Drugs
IG001119
03
Conditions
pain
Beyond the preview
Go deeper on NCT07618247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07618247.